StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
DBOL.NS$107.36+2.63%
Fair $107.36+0.0%

DBOL.NS

Dhampur Bio Organics Limited

Consumer Defensive / Farm ProductsNSE

$107.36

+2.77 (+2.63%)

Fairly Valued+0.0%Fair Value $107.36Fund rank 22/100 · Data gapFallback financials|
SA 40/C
F-Score: 3/9
Margin CompressionLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 16%

FCF escenarios

weak_data · normalized FCF $-161.7M · quality 33.7/100

Data gap 22/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 5/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

40/100

C

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 2unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Operating margin has declined for 3 consecutive years ROE is 1.5%, below the 5% threshold
Thesis & Journal · DBOL.NSLocal privado en este navegador · Dhampur Bio Organics Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$7.1B

P/E

30.2x

↑

EV/EBITDA

13.9x

↑

ROE

1.5%

↓

Gross Margin

19.3%

↓

Debt/Equity

1.15

↑
52-Week Range$107
$69$131

TradingView lightweight chart

DBOL.NS price, volumen y niveles de valoración

Último $107.95Periodo -35.8%
Fair value: $107.36

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+6.5%

FCF CAGR

—

FCF margin

-0.9%

FCF / Net income

-1.10x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $18.43B · net income $146.9M · FCF $-161.7M

2022-FY → 2025-FY

Gross margin

19.3%-2.8% pts

Operating margin

4.5%-5.7% pts

Net margin

0.8%-5.9% pts

FCF margin

-0.9%+24.9% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$18.43B$18.43B$18.39B$23.67B$15.27B
Net Income$146.9M$146.9M$464.9M$1.11B$1.02B
EBITDA$1.34B$1.34B$1.58B$2.13B$1.90B
EPS2.212.217.0016.7415.41
Gross Margin19.3%19.3%19.8%19.1%22.1%
Operating Margin4.5%4.5%5.0%7.3%10.2%
Net Margin0.8%0.8%2.5%4.7%6.7%
Balance Sheet
Debt/Equity1.151.151.040.820.95
Current Ratio1.171.17———
Cash Flow
Free Cash Flow$-161.7M$-161.7M$-2.72B$1.45B$-3.94B
Returns
ROE1.5%1.5%4.6%11.2%11.6%
Valuation
P/E30.1630.1619.309.08—
EV/EBITDA13.9113.9112.308.04—
P/B0.700.700.891.02—
Growth & Yield
Revenue Growth0.2%0.2%-22.3%55.0%—
EPS Growth-68.4%-68.4%-58.2%8.6%—
Dividend Yield1.2%1.2%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

62.7%

muy exigente

EPS terminal req.

$9.53

Spread vs growth

-131.2%

5Y implied EPS CAGR

39.1%

muy exigente

EPS terminal req.

$11.53

Spread vs growth

-107.6%

10Y implied EPS CAGR

23.7%

exigente

EPS terminal req.

$18.56

Spread vs growth

-92.1%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +42.1%

Total return

+42.1%

Start / end P/E

10.9x → 48.8x

EPS bridge

7.00 → 2.21

Residual

-237.0%

EPS growth-68.4%
Multiple rerating+346.4%
Dividend+1.2%
Residual / FX / buybacks / cross-term-237.0%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.